Old Web
English
Sign In
Acemap
>
authorDetail
>
Baerbel Seyfarth
Baerbel Seyfarth
Medicine
Immunology
Autologous stem-cell transplantation
Rituximab
CHOP
4
Papers
8
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Rituximab Improves the Outcome of Upfront Autologous Stem Cell Transplantation in Mantle Cell Lymphoma: A Comparison of Different Strategies.
2007
Blood
Michael A. Rieger
Mathias Witzens Harig
Manfred Hensel
Baerbel Seyfarth
Maike Nickelsen
Michael Kneba
Norbert Schmitz
Anthony D. Ho
Peter Dreger
Show All
Source
Cite
Save
Citations (1)
Upfront Autologous Stem Cell Transplantation (SCT) Ameliorates the Prognostic Disadvantage of an Intermediate/High-Risk FLIPI Score in Patients with Advanced Follicular Lymphoma (FL): Evidence from Two Independent Data Sets.
2005
Blood
Kornacker Martin
Simone Suessmilch
Hilde Gulla
Baerbel Seyfarth
Robert Schoch
Michael Kneba
Anthony D. Ho
Manfred Hensel
Norbert Schmitz
Peter Dreger
Show All
Source
Cite
Save
Citations (0)
Favorable Influence of Pretransplant Rituximab but Not of High-Dose Ara-C in Upfront Autologous Stem Cell Transplantation (SCT) for Mantle Cell Lymphoma (MCL).
2005
Blood
Michael A. Rieger
Manfred Hensel
Baerbel Seyfarth
Soeren Sitter
Simona Martin
Rainer Haas
Michael Kneba
Norbert Schmitz
Anthony D. Ho
Peter Dreger
Show All
Source
Cite
Save
Citations (1)
Thrombocytosis in Polymyalgia Rheumatica: An Additional Diagnostic Criterion and Possible Risk Factor for Ischemic Complications?
1998
JAMA Internal Medicine
Pontus Harten
Baerbel Seyfarth
Helmut Löffler
Show All
Source
Cite
Save
Citations (6)
1